
Protembis
Mitigating large brain lesions during TAVR.
$32.5M Series B+ ·
Source: startupintros.com
Total raised: $42.5M across 2 sourced rounds
All 2 rounds ↓Signals
Website registeredOct 3, 2013 (13 years old)
About Protembis
TAVR procedures can cause large brain infarcts, which may lead to procedural clinical stroke and an increased risk of future stroke, cognitive decline, and dementia.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $32.5M | — | startupintros.com | |
| Series A | $10M | — | startupintros.com |
Timeline
- Website created
Companies like Protembis
EEmboline$20M · Mar 2026IIvorySeed · Apr 2026
PPerfuze$26M Series A · Feb 2022
XXenter$58.25M Series B+ · Jul 2026CCarez AI
LLifeCyte Innovations$1M Seed · Aug 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/protembis (get a free API key).